Biocept, Inc. (BIOC)-Product Pipeline Analysis, 2016 Update

Biocept, Inc. (BIOC)-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME5968PD
  • |
  • Pages: 27
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biocept, Inc. (Biocept) is a medical equipment company that provides diagnostics services. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers OncoCEE technology, related instrumentation and analytical capabilities for rare event detection and genetic characterization. The company's OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company caters to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Biocept, Inc.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Biocept, Inc. Company Snapshot 5

Biocept, Inc. Company Overview 5

Biocept, Inc. Pipeline Products and Clinical Trials Overview 6

Biocept, Inc.-Pipeline Analysis Overview 8

Key Facts 8

Biocept, Inc.-Major Products and Services 9

Biocept, Inc. Pipeline Products by Development Stage 10

Biocept, Inc. Pipeline Products Overview 12

CTC Based Liquid Biopsy Test-ESR1 12

CTC Based Liquid Biopsy Test-ESR1 Product Overview 12

ctDNA Based Liquid Biopsy Test-ESR1 13

ctDNA Based Liquid Biopsy Test-ESR1 Product Overview 13

MicroRNA Test-Lung Cancer 14

MicroRNA Test-Lung Cancer Product Overview 14

OncoCEE-CR (FISH) 15

OncoCEE-CR (FISH) Product Overview 15

preCEED 16

preCEED Product Overview 16

Biocept, Inc.-Key Competitors 17

Biocept, Inc.-Key Employees 18

Biocept, Inc.-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Biocept, Inc., Recent Developments 20

May 31, 2016: Biocept Launches Liquid Biopsy Immuno-Oncology PD-L1 Test 20

May 25, 2016: High Sensitivity of Biocept's Target Selector Blood-Based Liquid Biopsy Tests Featured in Two Abstracts at ASCO 20

May 23, 2016: Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests 21

May 19, 2016: Biocept Launches Proprietary Liquid Biopsy Test to Detect RET Fusions in Patients with Lung Cancer 21

May 12, 2016: Biocept Expands Intellectual Property Portfolio with 12th Granted Patent on its Key Liquid Biopsy Technology 22

May 12, 2016: Biocept Reports 2016 First Quarter Financial Results 22

Apr 27, 2016: Biocept Collaborates with MedStar Georgetown University Hospital for Liquid Biopsy Study 23

Mar 23, 2016: Biocept's Mark Foletta Honored with CFO Lifetime Achievement Award 24

Mar 10, 2016: Progenetics to Distribute Biocept's Liquid Biopsy Assays in Israel 24

Mar 09, 2016: Biocept Reports 2015 Fourth Quarter and Full Year Financial Results 24

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27

List of Figures

Biocept, Inc. Pipeline Products by Equipment Type 7

Biocept, Inc. Pipeline Products by Development Stage 10

List of Tables

Biocept, Inc. Pipeline Products and Clinical Trials Overview 6

Biocept, Inc. Pipeline Products by Equipment Type 6

Biocept, Inc. Pipeline Products by Indication 7

Biocept, Inc., Key Facts 8

Biocept, Inc., Major Products and Services 9

Biocept, Inc. Number of Pipeline Products by Development Stage 10

Biocept, Inc. Pipeline Products Summary by Development Stage 11

CTC Based Liquid Biopsy Test-ESR1-Product Status 12

CTC Based Liquid Biopsy Test-ESR1-Product Description 12

ctDNA Based Liquid Biopsy Test-ESR1-Product Status 13

ctDNA Based Liquid Biopsy Test-ESR1-Product Description 13

MicroRNA Test-Lung Cancer-Product Status 14

MicroRNA Test-Lung Cancer-Product Description 14

OncoCEE-CR (FISH)-Product Status 15

OncoCEE-CR (FISH)-Product Description 15

preCEED-Product Status 16

preCEED-Product Description 16

Biocept, Inc., Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Celula, Inc.

AVIVA Biosciences Corporation

Argos Therapeutics, Inc.

ApoCell, Inc.

Affymax, Inc.

AdCare Health Systems, Inc.

Actinium Pharmaceuticals, Inc

Biocept, Inc., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48428
Site License
USD 1500 INR 96855
Corporate User License
USD 2250 INR 145283

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com